Driving performance
Showing 1 - 25 of >10,000
Stroke, Visual Impairment, Low Vision Trial in Toronto (Audiovisual Stimulation)
Not yet recruiting
- Stroke
- +8 more
- Audiovisual Stimulation
-
Toronto, Ontario, Canada
- +1 more
Feb 1, 2023
Driving Impaired, Cognitive Impairment, Abuse Cannabis Trial in Toronto (Cannabis, Placebo)
Completed
- Driving Impaired
- +2 more
- Cannabis
- Placebo
-
Toronto, Ontario, CanadaCenter for Addiction and Mental Health
Oct 5, 2022
Reactions of Older Adults Driving After Cannabis Exposure
Recruiting
- Chronic Pain
- Medical Cannabis
-
Gainesville, FloridaSmart House at Oak Hammock
Nov 29, 2022
Driving Performance, Cognitive Impairment, Sedation Complication Trial in Morgantown (300 mg Cannabidiol (CBD) oil, Placebo)
Completed
- Driving Performance
- +3 more
- 300 mg Cannabidiol (CBD) oil
- Placebo
-
Morgantown, West VirginiaWest Virginia University
Aug 21, 2022
Cannabis, Alcohol Drinking, Accident, Traffic Trial (THC 0, THC 5, THC 10)
Withdrawn
- Cannabis
- +2 more
- THC 0
- +5 more
- (no location specified)
Apr 20, 2022
Depressive Disorder, Major Trial in Alken, Aachen (Seltorexant Dose 1, Seltorexant Dose 2, Placebo)
Recruiting
- Depressive Disorder, Major
- Seltorexant Dose 1
- +3 more
-
Alken, Belgium
- +1 more
Aug 17, 2022
Parkinson Disease Trial in Gainesville (PD Drivers Using AV Technologies On-road)
Recruiting
- Parkinson Disease
- PD Drivers Using AV Technologies On-road
-
Gainesville, FloridaUF Norman Fixel Institute for Neurological Diseases
Mar 23, 2022
Healthy Subjects Trial in Tokyo (TS-142, Zopiclone, Placebo)
Completed
- Healthy Subjects
- TS-142
- +2 more
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Jan 12, 2022
Presbyopia Trial in Brisbane (AGN-190584)
Completed
- Presbyopia
-
Brisbane, Queensland, AustraliaSchool of Optometry and Vision Science, Queensland University of
Feb 11, 2022
ADHD Trial in Boston (Amphetamine Extended Release (ER) Tablet 20 mg)
Completed
- ADHD
- Amphetamine Extended Release (ER) Tablet 20 mg
-
Boston, MassachusettsMassachusetts General Hospital
Feb 16, 2022
Neurologic Disorder, Brain Injuries, Neurodegeneration Trial in Rennes (Immersive condition (CAVE), Immersive condition (HMD),
Completed
- Neurologic Disorder
- +2 more
- Immersive condition (CAVE)
- +3 more
-
Rennes, Bretagne, FrancePole Saint-Hélier
Oct 29, 2021
Driving Impaired Trial in Liège (Propofol, No sedation)
Completed
- Driving Impaired
- Propofol
- No sedation
-
Liège, BelgiumCentre hospitalier universitaire de Liege
Jun 23, 2021
Roux-en-Y Gastric Bypass, Postprandial Hypoglycemia, Driving Impaired Trial in Bern (Oral glucose tolerance test, Ingestion of )
Completed
- Roux-en-Y Gastric Bypass
- +2 more
- Oral glucose tolerance test
- Ingestion of placebo
-
Bern, SwitzerlandDepartment of Diabetes, Endocrinology, Clinical Nutrition and Me
Feb 17, 2021
Narcolepsy, Excessive Sleepiness Trial in Maastricht (JZP-110, Placebo)
Completed
- Narcolepsy
- Excessive Sleepiness
- JZP-110
- Placebo
-
Maastricht, Limburg, NetherlandsMaastricht University
Dec 21, 2020
Obstructive Sleep Apnea, Excessive Sleepiness Trial in Maastricht (JZP-110, Placebo)
Completed
- Obstructive Sleep Apnea
- Excessive Sleepiness
- JZP-110
- Placebo
-
Maastricht, Limburg, NetherlandsMaastricht University
Dec 21, 2020
Cannabis Intoxication Trial in San Diego (Cannabis)
Completed
- Cannabis Intoxication
-
San Diego, CaliforniaCenter for Medicinal Cannabis Research, UC San Diego
Dec 4, 2021
Cognitive Measures, Driving Simulator Performance Trial in Iowa City (Phenytoin, Placebo oral capsule)
Completed
- Cognitive Measures
- Driving Simulator Performance
- Phenytoin
- Placebo oral capsule
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
Jun 30, 2021
Hepatic Encephalopathy Trial in Richmond (Rifaximin, )
Completed
- Hepatic Encephalopathy
- Rifaximin
- placebo
-
Richmond, VirginiaHunter Holmes McGuire VA Medical Center
Dec 15, 2020
Attention Deficit Disorder With Hyperactivity Trial in Washington (Mixed salts of a single-entity amphetamine, Atomoxetine HCl)
Completed
- Attention Deficit Disorder With Hyperactivity
- Mixed salts of a single-entity amphetamine
- Atomoxetine hydrochloride
-
Washington, District of ColumbiaWashington Neuropsychological Institute, LLC
May 21, 2021
ADHD Trial in Tampa (SPD465, Placebo)
Withdrawn
- Attention Deficit Hyperactivity Disorder
- SPD465
- Placebo
-
Tampa, FloridaMeridien Research
Jul 1, 2021
Driving Tests to Evaluate Patient Performance on Oral Opioids
Active, not recruiting
- Chronic Pain
-
Chicago, IllinoisRush University Medical Center
Nov 18, 2020